Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.
The compound, called F6, has been potent against antibiotic-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), which is often found in hospitals and other health care settings, and vancomycin-resistant Staphylococcus aureus (VRSA), with vancomycin long considered a drug of last resort. The compound was tested against clinical isolates.
“This is very exciting,” said Herman Sintim, drug discovery professor in Purdue’s Department of Chemistry. “We are not the first to report of a new molecular entity that killed these drug-resistant pathogens. But what is unique about the compound that we found is that when we tried to generate resistance in the lab, we couldn’t.”
Antibiotic resistance is a growing public health crisis. The World Health Organization has deemed antibiotic resistance one of the three greatest threats to human health because bacteria are becoming increasingly resistant and too few treatments are being developed. The Centers for Disease Control and Prevention reports that at least 2 million people a year in the United States become infected with bacteria resistant to antibiotics and at least 23,000 people die a year as a result. Studies have estimated that drug-resistant infections could be responsible for 10 million deaths a year worldwide by 2050.
Pharmaceutical companies have been reluctant to invest in antibiotics because it typically costs millions of dollars to develop a drug and the probability of bacterial resistance is high.
Purdue researchers identified F6 by screening a chemical library for compounds with antibacterial activity. They tried to force bacteria resistance on F6, performing experiments to evaluate the ability of MRSA USA400 to develop resistance to F6 in vitro.
“The idea is that if you keep adding increasing concentrations to bacteria and then you keep regrowing the bacteria, after so many cycles you are going to develop resistance,” Sintim said. “Scientists do this to figure out whether whatever they have created develops resistance quickly.”
The minimal inhibitory concentration, or MIC, remained unchanged for F6 over nine passages and doubled on the10th passage. It then remained unchanged up to the 14th passage during a two-week period. By comparison, the MIC of the antibiotic ciprofloxacin tripled after the eighth passage and continued to rapidly increase to more than 2,000-fold by the 14th passage.
“We are not saying there will never be resistance to the F6 molecule or analogs thereof. What we are saying is that here is a new molecule that works and when we try to force resistance we couldn’t generate resistance,” Sintim said.
F6, which is nontoxic to humans and other mammals, works against bacteria in a group known as Gram-positive, but not against those that are Gram-negative. F6 was effective against MRSA, VRSA, Enterococcus faecalis, which lives in the human gut, vancomycin-resistant Enterococcus (VRE) and Listeria monocytogenes, often associated with unpasteurized dairy products.
Testing on mice also indicated F6 was as effective as fusidic acid in treating a wound infected with MRSA, further confirming its potent antibacterial effect.
The Purdue researchers will now begin to make derivatives of F6 to see if they might be even more effective. They are working with the Purdue Office of Technology Commercialization to look for partners to help further develop this exciting new molecular entity.
The Latest on: Antibiotic-resistant pathogens
[google_news title=”” keyword=”antibiotic-resistant pathogens” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antibiotic-resistant pathogens
- Drug-Resistant Bacteria in Space; Met Gala Medical Specialties; Misinfo on DOson May 9, 2024 at 11:31 am
In homage to "The Garden of Time" Met Gala theme, Jorge Zárate, MD, shared his third annual installment of Met Gala outfits themed around medical specialties. Ophthalmologist and comedian Dr.
- Changes in pig farming in the 20th century spread antibiotic-resistant Salmonella around the world, finds studyon May 9, 2024 at 7:44 am
Historical changes in pig farming led to the global spread of Salmonella, resistant to antibiotics—a new international study led by researchers at the University of Warwick suggests.
- Antibiotic-resistant Salmonella was spread by intensive pig farmingon May 9, 2024 at 5:15 am
Changes to made to pig farming practises during the 20th century led to the spread of antibiotic-resistant Salmonella around the world, new research suggests.
- A New Oral Antibiotic Is Available to Treat UTIson May 8, 2024 at 9:32 am
The FDA recently approved Pivya for uncomplicated UTIs. Pivya is an oral tablet that clears bacterial infections in the female bladder.
- Study underscores new strategies to fight drug-resistant bacteriaon May 7, 2024 at 12:41 pm
Several billion years ago, a genetic arms race began between bacteria and their viral killers. This seemingly eternal struggle continues today, with implications for diseases killing tens of thousands ...
- Fred Allendorf: Science and Nature: Evolution of antibiotic resistance in bacteriaon May 7, 2024 at 5:45 am
Approximately 8 million people die annually around the world from infectious diseases caused by bacteria. Bacterial diseases have been the major cause of human mortality throughout history. For ...
- A mother's loss launches a global effort to fight antibiotic resistanceon May 7, 2024 at 3:00 am
Diane Shader Smith's daughter, Mallory Smith, died at age 25 after fighting an antibiotic-resistant lung infection for 12 years. A new book of her daughter's diary entries and a website are aimed at ...
- Raw meat-based diet for pets linked to drug-resistant bacteria, prompting concerns over public health riskson May 5, 2024 at 10:51 pm
Study reveals that raw meat-based pet diets (RMBDs) often harbor multidrug-resistant bacteria, posing significant health risks to both pets and humans, unlike conventionally processed pet foods.
- Antimicrobial peptide from cows shows potential for treating hypervirulent bacteriaon May 2, 2024 at 6:34 am
University of Central Florida College of Medicine researcher Renee Fleeman is on a mission to kill drug-resistant bacteria, and her latest study has identified a therapy that can penetrate the slime ...
via Bing News